Global Tuberculosis (TB) Diagnostics Market 2021 by Company, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 164096
  • calendar_today Published On: Feb, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Tuberculosis (TB) Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Tuberculosis (TB) Diagnostics size is estimated to be USD 3068.7 million in 2026 from USD 2592.4 million in 2020, with a change XX% between 2020 and 2021. The global Tuberculosis (TB) Diagnostics market size is expected to grow at a CAGR of 4.3% for the next five years.

Market segmentation

Tuberculosis (TB) Diagnostics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Culture-Based Diagnostics

Sputum Smear Microscopy

Rapid Molecular Diagnostics

Others

Market segment by Application, can be divided into

Diagnostic Laboratories

Hospitals

Others

Market segment by players, this report covers

Danaher

Roche

Thermo Fisher Scientific

BD

Abbott

Hologic

Qiagen

BioMerieux

Hain Lifescience

Oxford Immunotec

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Tuberculosis (TB) Diagnostics

1.2 Classification of Tuberculosis (TB) Diagnostics by Type

1.2.1 Overview: Global Tuberculosis (TB) Diagnostics Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Tuberculosis (TB) Diagnostics Revenue Market Share by Type in 2020

1.2.3 Culture-Based Diagnostics

1.2.4 Sputum Smear Microscopy

1.2.5 Rapid Molecular Diagnostics

1.2.6 Others

1.3 Global Tuberculosis (TB) Diagnostics Market by Application

1.3.1 Overview: Global Tuberculosis (TB) Diagnostics Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Diagnostic Laboratories

1.3.3 Hospitals

1.3.4 Others

1.4 Global Tuberculosis (TB) Diagnostics Market Size & Forecast

1.5 Global Tuberculosis (TB) Diagnostics Market Size and Forecast by Region

1.5.1 Global Tuberculosis (TB) Diagnostics Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Tuberculosis (TB) Diagnostics Market Size by Region, (2016-2021)

1.5.3 North America Tuberculosis (TB) Diagnostics Market Size and Prospect (2016-2026)

1.5.4 Europe Tuberculosis (TB) Diagnostics Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size and Prospect (2016-2026)

1.5.6 South America Tuberculosis (TB) Diagnostics Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Tuberculosis (TB) Diagnostics Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Tuberculosis (TB) Diagnostics Market Drivers

1.6.2 Tuberculosis (TB) Diagnostics Market Restraints

1.6.3 Tuberculosis (TB) Diagnostics Trends Analysis

2 Company Profiles

2.1 Danaher

2.1.1 Danaher Details

2.1.2 Danaher Major Business

2.1.3 Danaher Tuberculosis (TB) Diagnostics Product and Solutions

2.1.4 Danaher Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Danaher Recent Developments and Future Plans

2.2 Roche

2.2.1 Roche Details

2.2.2 Roche Major Business

2.2.3 Roche Tuberculosis (TB) Diagnostics Product and Solutions

2.2.4 Roche Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Roche Recent Developments and Future Plans

2.3 Thermo Fisher Scientific

2.3.1 Thermo Fisher Scientific Details

2.3.2 Thermo Fisher Scientific Major Business

2.3.3 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Product and Solutions

2.3.4 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Thermo Fisher Scientific Recent Developments and Future Plans

2.4 BD

2.4.1 BD Details

2.4.2 BD Major Business

2.4.3 BD Tuberculosis (TB) Diagnostics Product and Solutions

2.4.4 BD Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 BD Recent Developments and Future Plans

2.5 Abbott

2.5.1 Abbott Details

2.5.2 Abbott Major Business

2.5.3 Abbott Tuberculosis (TB) Diagnostics Product and Solutions

2.5.4 Abbott Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Abbott Recent Developments and Future Plans

2.6 Hologic

2.6.1 Hologic Details

2.6.2 Hologic Major Business

2.6.3 Hologic Tuberculosis (TB) Diagnostics Product and Solutions

2.6.4 Hologic Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Hologic Recent Developments and Future Plans

2.7 Qiagen

2.7.1 Qiagen Details

2.7.2 Qiagen Major Business

2.7.3 Qiagen Tuberculosis (TB) Diagnostics Product and Solutions

2.7.4 Qiagen Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Qiagen Recent Developments and Future Plans

2.8 BioMerieux

2.8.1 BioMerieux Details

2.8.2 BioMerieux Major Business

2.8.3 BioMerieux Tuberculosis (TB) Diagnostics Product and Solutions

2.8.4 BioMerieux Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 BioMerieux Recent Developments and Future Plans

2.9 Hain Lifescience

2.9.1 Hain Lifescience Details

2.9.2 Hain Lifescience Major Business

2.9.3 Hain Lifescience Tuberculosis (TB) Diagnostics Product and Solutions

2.9.4 Hain Lifescience Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Hain Lifescience Recent Developments and Future Plans

2.10 Oxford Immunotec

2.10.1 Oxford Immunotec Details

2.10.2 Oxford Immunotec Major Business

2.10.3 Oxford Immunotec Tuberculosis (TB) Diagnostics Product and Solutions

2.10.4 Oxford Immunotec Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Oxford Immunotec Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Tuberculosis (TB) Diagnostics Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Tuberculosis (TB) Diagnostics Players Market Share

3.2.2 Top 10 Tuberculosis (TB) Diagnostics Players Market Share

3.2.3 Market Competition Trend

3.3 Tuberculosis (TB) Diagnostics Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Tuberculosis (TB) Diagnostics Revenue and Market Share by Type (2016-2021)

4.2 Global Tuberculosis (TB) Diagnostics Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Tuberculosis (TB) Diagnostics Revenue Market Share by Application (2016-2021)

5.2 Tuberculosis (TB) Diagnostics Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Tuberculosis (TB) Diagnostics Revenue by Type (2016-2026)

6.2 North America Tuberculosis (TB) Diagnostics Revenue by Application (2016-2026)

6.3 North America Tuberculosis (TB) Diagnostics Market Size by Country

6.3.1 North America Tuberculosis (TB) Diagnostics Revenue by Country (2016-2026)

6.3.2 United States Tuberculosis (TB) Diagnostics Market Size and Forecast (2016-2026)

6.3.3 Canada Tuberculosis (TB) Diagnostics Market Size and Forecast (2016-2026)

6.3.4 Mexico Tuberculosis (TB) Diagnostics Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Tuberculosis (TB) Diagnostics Revenue by Type (2016-2026)

7.2 Europe Tuberculosis (TB) Diagnostics Revenue by Application (2016-2026)

7.3 Europe Tuberculosis (TB) Diagnostics Market Size by Country

7.3.1 Europe Tuberculosis (TB) Diagnostics Revenue by Country (2016-2026)

7.3.2 Germany Tuberculosis (TB) Diagnostics Market Size and Forecast (2016-2026)

7.3.3 France Tuberculosis (TB) Diagnostics Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Tuberculosis (TB) Diagnostics Market Size and Forecast (2016-2026)

7.3.5 Russia Tuberculosis (TB) Diagnostics Market Size and Forecast (2016-2026)

7.3.6 Italy Tuberculosis (TB) Diagnostics Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Tuberculosis (TB) Diagnostics Revenue by Type (2016-2026)

8.2 Asia-Pacific Tuberculosis (TB) Diagnostics Revenue by Application (2016-2026)

8.3 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size by Region

8.3.1 Asia-Pacific Tuberculosis (TB) Diagnostics Revenue by Region (2016-2026)

8.3.2 China Tuberculosis (TB) Diagnostics Market Size and Forecast (2016-2026)

8.3.3 Japan Tuberculosis (TB) Diagnostics Market Size and Forecast (2016-2026)

8.3.4 South Korea Tuberculosis (TB) Diagnostics Market Size and Forecast (2016-2026)

8.3.5 India Tuberculosis (TB) Diagnostics Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Tuberculosis (TB) Diagnostics Market Size and Forecast (2016-2026)

8.3.7 Australia Tuberculosis (TB) Diagnostics Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Tuberculosis (TB) Diagnostics Revenue by Type (2016-2026)

9.2 South America Tuberculosis (TB) Diagnostics Revenue by Application (2016-2026)

9.3 South America Tuberculosis (TB) Diagnostics Market Size by Country

9.3.1 South America Tuberculosis (TB) Diagnostics Revenue by Country (2016-2026)

9.3.2 Brazil Tuberculosis (TB) Diagnostics Market Size and Forecast (2016-2026)

9.3.3 Argentina Tuberculosis (TB) Diagnostics Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Tuberculosis (TB) Diagnostics Revenue by Type (2016-2026)

10.2 Middle East & Africa Tuberculosis (TB) Diagnostics Revenue by Application (2016-2026)

10.3 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Country

10.3.1 Middle East & Africa Tuberculosis (TB) Diagnostics Revenue by Country (2016-2026)

10.3.2 Turkey Tuberculosis (TB) Diagnostics Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Tuberculosis (TB) Diagnostics Market Size and Forecast (2016-2026)

10.3.4 UAE Tuberculosis (TB) Diagnostics Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Tuberculosis (TB) Diagnostics Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Tuberculosis (TB) Diagnostics Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Tuberculosis (TB) Diagnostics Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Tuberculosis (TB) Diagnostics Revenue (USD Million) by Region (2016-2021)

Table 5. Global Tuberculosis (TB) Diagnostics Revenue Market Share by Region (2021-2026)

Table 6. Danaher Corporate Information, Head Office, and Major Competitors

Table 7. Danaher Major Business

Table 8. Danaher Tuberculosis (TB) Diagnostics Product and Solutions

Table 9. Danaher Tuberculosis (TB) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Roche Corporate Information, Head Office, and Major Competitors

Table 11. Roche Major Business

Table 12. Roche Tuberculosis (TB) Diagnostics Product and Solutions

Table 13. Roche Tuberculosis (TB) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors

Table 15. Thermo Fisher Scientific Major Business

Table 16. Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Product and Solutions

Table 17. Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. BD Corporate Information, Head Office, and Major Competitors

Table 19. BD Major Business

Table 20. BD Tuberculosis (TB) Diagnostics Product and Solutions

Table 21. BD Tuberculosis (TB) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Abbott Corporate Information, Head Office, and Major Competitors

Table 23. Abbott Major Business

Table 24. Abbott Tuberculosis (TB) Diagnostics Product and Solutions

Table 25. Abbott Tuberculosis (TB) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Hologic Corporate Information, Head Office, and Major Competitors

Table 27. Hologic Major Business

Table 28. Hologic Tuberculosis (TB) Diagnostics Product and Solutions

Table 29. Hologic Tuberculosis (TB) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Qiagen Corporate Information, Head Office, and Major Competitors

Table 31. Qiagen Major Business

Table 32. Qiagen Tuberculosis (TB) Diagnostics Product and Solutions

Table 33. Qiagen Tuberculosis (TB) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. BioMerieux Corporate Information, Head Office, and Major Competitors

Table 35. BioMerieux Major Business

Table 36. BioMerieux Tuberculosis (TB) Diagnostics Product and Solutions

Table 37. BioMerieux Tuberculosis (TB) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Hain Lifescience Corporate Information, Head Office, and Major Competitors

Table 39. Hain Lifescience Major Business

Table 40. Hain Lifescience Tuberculosis (TB) Diagnostics Product and Solutions

Table 41. Hain Lifescience Tuberculosis (TB) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Oxford Immunotec Corporate Information, Head Office, and Major Competitors

Table 43. Oxford Immunotec Major Business

Table 44. Oxford Immunotec Tuberculosis (TB) Diagnostics Product and Solutions

Table 45. Oxford Immunotec Tuberculosis (TB) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Global Tuberculosis (TB) Diagnostics Revenue (USD Million) by Players (2019-2021)

Table 47. Global Tuberculosis (TB) Diagnostics Revenue Share by Players (2019-2021)

Table 48. Breakdown of Tuberculosis (TB) Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3)

Table 49. Tuberculosis (TB) Diagnostics Players Head Office, Products and Services Provided

Table 50. Tuberculosis (TB) Diagnostics Mergers & Acquisitions in the Past Five Years

Table 51. Tuberculosis (TB) Diagnostics New Entrants and Expansion Plans

Table 52. Global Tuberculosis (TB) Diagnostics Revenue (USD Million) by Type (2016-2021)

Table 53. Global Tuberculosis (TB) Diagnostics Revenue Share by Type (2016-2021)

Table 54. Global Tuberculosis (TB) Diagnostics Revenue Forecast by Type (2021-2026)

Table 55. Global Tuberculosis (TB) Diagnostics Revenue by Application (2016-2021)

Table 56. Global Tuberculosis (TB) Diagnostics Revenue Forecast by Application (2021-2026)

Table 57. North America Tuberculosis (TB) Diagnostics Revenue by Type (2016-2021) & (USD Million)

Table 58. North America Tuberculosis (TB) Diagnostics Revenue by Type (2021-2026) & (USD Million)

Table 59. North America Tuberculosis (TB) Diagnostics Revenue by Application (2016-2021) & (USD Million)

Table 60. North America Tuberculosis (TB) Diagnostics Revenue by Application (2021-2026) & (USD Million)

Table 61. North America Tuberculosis (TB) Diagnostics Revenue by Country (2016-2021) & (USD Million)

Table 62. North America Tuberculosis (TB) Diagnostics Revenue by Country (2021-2026) & (USD Million)

Table 63. Europe Tuberculosis (TB) Diagnostics Revenue by Type (2016-2021) & (USD Million)

Table 64. Europe Tuberculosis (TB) Diagnostics Revenue by Type (2021-2026) & (USD Million)

Table 65. Europe Tuberculosis (TB) Diagnostics Revenue by Application (2016-2021) & (USD Million)

Table 66. Europe Tuberculosis (TB) Diagnostics Revenue by Application (2021-2026) & (USD Million)

Table 67. Europe Tuberculosis (TB) Diagnostics Revenue by Country (2016-2021) & (USD Million)

Table 68. Europe Tuberculosis (TB) Diagnostics Revenue by Country (2021-2026) & (USD Million)

Table 69. Asia-Pacific Tuberculosis (TB) Diagnostics Revenue by Type (2016-2021) & (USD Million)

Table 70. Asia-Pacific Tuberculosis (TB) Diagnostics Revenue by Type (2021-2026) & (USD Million)

Table 71. Asia-Pacific Tuberculosis (TB) Diagnostics Revenue by Application (2016-2021) & (USD Million)

Table 72. Asia-Pacific Tuberculosis (TB) Diagnostics Revenue by Application (2021-2026) & (USD Million)

Table 73. Asia-Pacific Tuberculosis (TB) Diagnostics Revenue by Region (2016-2021) & (USD Million)

Table 74. Asia-Pacific Tuberculosis (TB) Diagnostics Revenue by Region (2021-2026) & (USD Million)

Table 75. South America Tuberculosis (TB) Diagnostics Revenue by Type (2016-2021) & (USD Million)

Table 76. South America Tuberculosis (TB) Diagnostics Revenue by Type (2021-2026) & (USD Million)

Table 77. South America Tuberculosis (TB) Diagnostics Revenue by Application (2016-2021) & (USD Million)

Table 78. South America Tuberculosis (TB) Diagnostics Revenue by Application (2021-2026) & (USD Million)

Table 79. South America Tuberculosis (TB) Diagnostics Revenue by Country (2016-2021) & (USD Million)

Table 80. South America Tuberculosis (TB) Diagnostics Revenue by Country (2021-2026) & (USD Million)

Table 81. Middle East & Africa Tuberculosis (TB) Diagnostics Revenue by Type (2016-2021) & (USD Million)

Table 82. Middle East & Africa Tuberculosis (TB) Diagnostics Revenue by Type (2021-2026) & (USD Million)

Table 83. Middle East & Africa Tuberculosis (TB) Diagnostics Revenue by Application (2016-2021) & (USD Million)

Table 84. Middle East & Africa Tuberculosis (TB) Diagnostics Revenue by Application (2021-2026) & (USD Million)

Table 85. Middle East & Africa Tuberculosis (TB) Diagnostics Revenue by Country (2016-2021) & (USD Million)

Table 86. Middle East & Africa Tuberculosis (TB) Diagnostics Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Tuberculosis (TB) Diagnostics Picture

Figure 2. Global Tuberculosis (TB) Diagnostics Revenue Market Share by Type in 2020

Figure 3. Culture-Based Diagnostics

Figure 4. Sputum Smear Microscopy

Figure 5. Rapid Molecular Diagnostics

Figure 6. Others

Figure 7. Tuberculosis (TB) Diagnostics Revenue Market Share by Application in 2020

Figure 8. Diagnostic Laboratories Picture

Figure 9. Hospitals Picture

Figure 10. Others Picture

Figure 11. Global Tuberculosis (TB) Diagnostics Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 12. Global Tuberculosis (TB) Diagnostics Revenue and Forecast (2016-2026) & (USD Million)

Figure 13. Global Tuberculosis (TB) Diagnostics Revenue Market Share by Region (2016-2026)

Figure 14. Global Tuberculosis (TB) Diagnostics Revenue Market Share by Region in 2020

Figure 15. North America Tuberculosis (TB) Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 16. Europe Tuberculosis (TB) Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. Asia-Pacific Tuberculosis (TB) Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. South America Tuberculosis (TB) Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 19. Middle East and Africa Tuberculosis (TB) Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 20. Tuberculosis (TB) Diagnostics Market Drivers

Figure 21. Tuberculosis (TB) Diagnostics Market Restraints

Figure 22. Tuberculosis (TB) Diagnostics Market Trends

Figure 23. Danaher Recent Developments and Future Plans

Figure 24. Roche Recent Developments and Future Plans

Figure 25. Thermo Fisher Scientific Recent Developments and Future Plans

Figure 26. BD Recent Developments and Future Plans

Figure 27. Abbott Recent Developments and Future Plans

Figure 28. Hologic Recent Developments and Future Plans

Figure 29. Qiagen Recent Developments and Future Plans

Figure 30. BioMerieux Recent Developments and Future Plans

Figure 31. Hain Lifescience Recent Developments and Future Plans

Figure 32. Oxford Immunotec Recent Developments and Future Plans

Figure 33. Global Tuberculosis (TB) Diagnostics Revenue Share by Players in 2020

Figure 34. Tuberculosis (TB) Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 35. Global Top 3 Players Tuberculosis (TB) Diagnostics Revenue Market Share in 2020

Figure 36. Global Top 10 Players Tuberculosis (TB) Diagnostics Revenue Market Share in 2020

Figure 37. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 38. Global Tuberculosis (TB) Diagnostics Revenue Share by Type in 2020

Figure 39. Global Tuberculosis (TB) Diagnostics Market Share Forecast by Type (2021-2026)

Figure 40. Global Tuberculosis (TB) Diagnostics Revenue Share by Application in 2020

Figure 41. Global Tuberculosis (TB) Diagnostics Market Share Forecast by Application (2021-2026)

Figure 42. North America Tuberculosis (TB) Diagnostics Sales Market Share by Type (2016-2026)

Figure 43. North America Tuberculosis (TB) Diagnostics Sales Market Share by Application (2016-2026)

Figure 44. North America Tuberculosis (TB) Diagnostics Revenue Market Share by Country (2016-2026)

Figure 45. United States Tuberculosis (TB) Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 46. Canada Tuberculosis (TB) Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 47. Mexico Tuberculosis (TB) Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 48. Europe Tuberculosis (TB) Diagnostics Sales Market Share by Type (2016-2026)

Figure 49. Europe Tuberculosis (TB) Diagnostics Sales Market Share by Application (2016-2026)

Figure 50. Europe Tuberculosis (TB) Diagnostics Revenue Market Share by Country (2016-2026)

Figure 51. Germany Tuberculosis (TB) Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 52. France Tuberculosis (TB) Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 53. United Kingdom Tuberculosis (TB) Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 54. Russia Tuberculosis (TB) Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 55. Italy Tuberculosis (TB) Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. Asia-Pacific Tuberculosis (TB) Diagnostics Sales Market Share by Type (2016-2026)

Figure 57. Asia-Pacific Tuberculosis (TB) Diagnostics Sales Market Share by Application (2016-2026)

Figure 58. Asia-Pacific Tuberculosis (TB) Diagnostics Revenue Market Share by Region (2016-2026)

Figure 59. China Tuberculosis (TB) Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. Japan Tuberculosis (TB) Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. South Korea Tuberculosis (TB) Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. India Tuberculosis (TB) Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. Southeast Asia Tuberculosis (TB) Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. Australia Tuberculosis (TB) Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. South America Tuberculosis (TB) Diagnostics Sales Market Share by Type (2016-2026)

Figure 66. South America Tuberculosis (TB) Diagnostics Sales Market Share by Application (2016-2026)

Figure 67. South America Tuberculosis (TB) Diagnostics Revenue Market Share by Country (2016-2026)

Figure 68. Brazil Tuberculosis (TB) Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 69. Argentina Tuberculosis (TB) Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 70. Middle East and Africa Tuberculosis (TB) Diagnostics Sales Market Share by Type (2016-2026)

Figure 71. Middle East and Africa Tuberculosis (TB) Diagnostics Sales Market Share by Application (2016-2026)

Figure 72. Middle East and Africa Tuberculosis (TB) Diagnostics Revenue Market Share by Country (2016-2026)

Figure 73. Turkey Tuberculosis (TB) Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 74. Saudi Arabia Tuberculosis (TB) Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 75. UAE Tuberculosis (TB) Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 76. Methodology

Figure 77. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz